We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,209 results
  1. MR-guided HDR prostate brachytherapy with teleoperated steerable needles

    Conformity of tumour volumes and dose plans in prostate brachytherapy (BT) can be constrained by unwanted needle deflections, needle access...

    M. de Vries, M. Wijntjes, ... S. Misra in Journal of Robotic Surgery
    Article Open access 22 July 2023
  2. Feasibility of MRI targeted single fraction HDR brachytherapy for localized prostate carcinoma: ProFocAL-study

    Purpose

    A potential method for focal therapy in locally advanced prostate cancer is focal brachytherapy (F-BT). The purpose of this research was to...

    Peter Hass, Frank Fischbach, ... Ahmed Gawish in Journal of Cancer Research and Clinical Oncology
    Article Open access 29 November 2022
  3. Basal Cell Carcinoma After High Dose Rate Brachytherapy: Medium-term Dermoscopic Evaluation of Cancer’s Response

    Introduction

    Basal cell carcinoma of the facial region remains a challenge for contemporary oncology due to the presence of aesthetic regions and...

    Tomasz Krzysztofiak, Magdalena Suchorzepka, ... Grażyna Kamińska-Winciorek in Dermatology and Therapy
    Article Open access 09 August 2023
  4. Clinical characteristics of secondary bladder cancer develo** after low-/high-dose-rate brachytherapy to treat localized prostate cancer

    Background

    To explore correlations between the clinical attributes of secondary bladder cancer and brachytherapy, we retrospectively reviewed our...

    Keiichiro Miyajima, Hirotaka Suzuki, ... Takahiro Kimura in International Journal of Clinical Oncology
    Article 11 July 2023
  5. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases

    Background

    Locoregional therapies, as imaging-guided tumor-directed procedures, are emerging treatment strategies in the management of primary and...

    Robert Damm, Maciej Pech, ... Borna Relja in Journal of Cancer Research and Clinical Oncology
    Article Open access 21 May 2022
  6. Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy

    Background

    Although brachytherapy is a standard treatment option for patients with high-risk prostate cancer, only a few studies have compared...

    Yu Imai, Fumihiko Urabe, ... Takahiro Kimura in International Journal of Clinical Oncology
    Article 22 February 2023
  7. Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients

    Background and purpose

    Comparing oncological outcomes and toxicity after primary treatment of localized prostate cancer using HDR- or...

    Matthias Moll, Elisabeth Nechvile, ... Gregor Goldner in Strahlentherapie und Onkologie
    Article Open access 15 March 2024
  8. Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis

    Purpose

    This monocentric study aimed to assess the impact of technical advancement in brachytherapy (BT) on local control (LC) and cancer-specific...

    Johanne Hermesse, Clémence Pleyers, ... Frédéric Kridelka in Strahlentherapie und Onkologie
    Article 09 August 2022
  9. Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer

    Purpose

    Until March 2018, patients with high-risk localized prostate cancer had been administered high-dose-rate brachytherapy (HDR-BT) combined with...

    Nobuhiko Kamitani, Kenta Watanabe, ... Kuniaki Katsui in Japanese Journal of Radiology
    Article Open access 29 June 2024
  10. Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial

    Aim

    To investigate the impact of pentoxifylline (PTX, 3 × 400 mg per day) and ursodeoxycholic acid (UDCA, 3 × 250 mg per day) administered for...

    Robert Damm, Joanna Wybranska, ... Max Seidensticker in Journal of Cancer Research and Clinical Oncology
    Article Open access 11 May 2023
  11. Comparison of two high dose rate intracavitary brachytherapy regimens in treatment of cervical cancer: a preliminary report

    Background

    To assess and compare the local control and toxicities between HDR Intracavitary Brachytherapy with 7.5 Gy and 9 Gy per fraction after EBRT...

    Abhishek Krishna, AG Hasib, ... Dilson Lobo in Discover Oncology
    Article Open access 29 March 2023
  12. Status of head and neck brachytherapy in Spain in 2022

    Purpose

    Brachytherapy (BT) has been used for many years for disease control in tumours of the head and neck area (H&N). It is currently performed with...

    Jose Luis Guinot, Patricia Diezhandino, ... Elena Villafranca in Clinical and Translational Oncology
    Article 07 August 2023
  13. Recommendations of the Spanish brachytherapy group of the Spanish Society of Radiation Oncology and the Spanish Society of Medical Physics for interstitial high-dose-rate brachytherapy for gynaecologic malignancies

    The present document includes consensus-based recommendations from the Brachytherapy Group (GEB) of the Spanish Society of Radiation Oncology (SEOR)...

    Cristina Gutiérrez Miguélez, Silvia Rodríguez Villalba, ... Dina Najjari-Jamal in Clinical and Translational Oncology
    Article Open access 29 November 2022
  14. Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis

    Background

    High-dose-rate brachytherapy (HDR-BT) plays an important role in the treatment of locally recurrent prostate cancer after definitive...

    Bin Shen, Jianjiang Liu, ... Jiayi Guo in Strahlentherapie und Onkologie
    Article 22 February 2024
  15. High dose rate endoluminal brachytherapy in the treatment of endobronchial lesions — experience of a single institution and literature review

    Purpose

    To evaluate the efficacy and toxicity of Iridium-192 high-dose-rate endobronchial brachytherapy (HDR-EBT) for palliation of symptoms and for...

    María Jesús Macías-Lozano, Verónica Díaz-Díaz, ... Javier Jaén-Olasolo in Supportive Care in Cancer
    Article 13 April 2023
  16. Pilot Evaluation of Perioperative High Dose Rate Brachytherapy in Head Neck Cancers

    Perioperative high dose rate brachytherapy involves insertion of brachytherapy catheter over the tumor bed during surgical removal of disease...

    Amit Bahl, Naresh K. Panda, ... Jaimanti Bakshi in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 08 January 2024
  17. Safety and efficacy of salvage high-dose rate brachytherapy for prostate-bed recurrences following radical prostatectomy and external beam radiotherapy

    Purpose

    This retrospective study aims to evaluate the efficacy and safety of salvage HDR brachytherapy in second local recurrences of prostate cancer...

    Mahdi Aghili, Fatemeh Jafari, ... Francesco Cuccia in International Urology and Nephrology
    Article 03 March 2022
  18. The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation

    Background

    Although the optimal management of locally advanced prostate cancer (PCa) remains unclear, local definitive therapy, thus combined...

    Soshi Kadena, Fumihiko Urabe, ... Takahiro Kimura in International Journal of Clinical Oncology
    Article 25 May 2023
  19. Survey on brachytherapy training among radiation oncology residents in the German-speaking regions of Europe

    Purpose

    This survey aimed to determine the perception of brachytherapy training among residents in the DACH region, consisting of Austria, Germany and...

    Johannes Knoth, Stefan Konrad, ... Stefanie Corradini in Strahlentherapie und Onkologie
    Article Open access 18 July 2023
  20. Dosimetric comparison of volumetric modulated arc therapy (VMAT) and high-dose-rate brachytherapy (HDR-BT) for superficial skin irradiation with significant curvature in one or more planes

    Purpose

    This study compares the plan quality of high-dose-rate brachytherapy (HDR-BT) and volumetric modulated arc therapy (VMAT) for superficial...

    Rachel J. Wills, Gerry Lowe, ... Peter J. Hoskin in Strahlentherapie und Onkologie
    Article 31 March 2021
Did you find what you were looking for? Share feedback.